arrow
返回
A

Andrea De Giglio

University of Bologna

30H指数
161论文数
3.7K被引数
收录论文 54
发表时间
Host-derived immunometabolic biomarkers identify prognostic profiles under immunotherapy in advanced NSCLC: the SARC-LUNG study宿主衍生的免疫代谢生物标志物可识别免疫治疗下晚期非小细胞肺癌的预后特征:SARC-LUNG研究
err2026-09-11
err0
errOAAI
errAndrea De Giglio; Maria Conte; Simona Coco; Francesco Galuppi; Sara Santamaria; Alessandra Rosa; Francesca Lo Bianco; Maria Naddeo; Ilaria Ricciotti; Alessandro Di Federico; Valentina Favorito; Lorenzo Trofarello; Francesco Mantuano; Francesca Sperandi; Francesco Gelsomino; Stefano Brocchi; Cristina Mosconi; Carlo Genova; Stefano Salvioli; Andrea Ardizzoni
err分享
err收藏
Corrigendum to “Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed” [Eur J Cancer 202, May 2024, 114006]对“意大利接受一线帕博利珠单抗联合铂类/培美曲塞治疗的晚期非鳞状细胞肺癌患者的真实世界结局”的勘误 [Eur J Cancer 202, 2024年5月, 114006]
err2026-06-27
err0
PREAI
errAlessandro Leonetti; Fabiana Perrone; Matteo Puntoni; Giuseppe Maglietta; Paola Bordi; Emilio Bria; Emanuele Vita; Francesco Gelsomino; Andrea De Giglio; Alain Gelibter; Marco Siringo; Francesca Mazzoni; Enrico Caliman; Carlo Genova; Federica Bertolini; Giorgia Guaitoli; Francesco Passiglia; Marco Donatello Delcuratolo; Michele Montrone; Giulio Cerea
err分享
err收藏
Immunotherapy beyond progression combined with platinum-based chemotherapy after primary resistance to first-line immunotherapy in patients with advanced NSCLC and PD-L1 ≥50%PD-L1 ≥50%的晚期非小细胞肺癌患者,在初次免疫治疗原发性耐药后,采用疾病进展后联合铂类为基础的化疗的免疫治疗。
err2025-11-17
err0
errOAAI
errA. De Giglio; L. Zullo; A. Di Federico; M. Cani; M. Aldea; D. Soldato; F.G. Dall’Olio; F. Mantuano; F. Sperandi; V. Favorito; A. Sadowska; L.E.L. Hendriks; T. Gorria; L. Mezquita; F. Tabbò; S. Novello; F. Gelsomino; B. Besse; A. Ardizzoni
err分享
err收藏
Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity长期接受帕博利珠单抗单药治疗的患者中,具有晚期非小细胞肺癌、PD-L1表达≥50%且体力状况较差者的长期结局:基于Transformer的AI用于表征预后复杂性
err2025-10-16
err0
errOAAI
errAlessio Cortellini; Edoardo Garbo; Giulia La Cava; Fabrizio Citarella; Valentina Santo; Leonardo Brunetti; David J Pinato; Jarushka Naidoo; Monica Loza; Carlo Genova; Scott Gettinger; So Yeon Kim; Ritujith Jayakrishnan; Talal El Zarif; Marco Russano; Federica Pecci; Alessandro Di Federico; Michele Montrone; Dwight H Owen; Diego Signorelli; Mingjia Li; Andrea Camerini; Balazs Halmos; Bruno Vincenzi; Giulio Metro; Sai Yendamuri; Francesco Grossi; Eleni Josephides; Bartłomiej Tomasik; Raffaele Giusti; Emilio Bria; Martin Sebastian; Maximilian Rost; Fabian Acker; Lorenza Landi; Francesca Mazzoni; Alessandro Morabito; Alessandro Leonetti; Luca Cantini; Giannis Mountzios; Sukumar Kalvapudi; David O’Reilly; Eleni Karapanagiotou; Isabelle Monnet; Javier Baena; Marianna Macerelli; Margarita Majem; Aida Piedra; Diego L Cortinovis; Giuseppe Tonini; Gabriele Minuti; Laura Mezquita; Teresa Gorria; Teresa Beninato; Giuseppe Lo Russo; Arsela PrelaJ; Andrea De Giglio; Federica Biello; Frank Aboubakar Nana; Anne-Marie C. Dingemans; Joachim GJV Aerts; Roberto Ferrara; Taher Abu Hejleh; Kazuki Takada; Abdul R Naqash; Marina C Garassino; Heather A. Wakelee; Amin Nassar; Biagio Ricciuti; Paolo Soda; Camillo Maria Caruso; Valerio Guarrasi
err分享
err收藏
Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis晚期非小细胞肺癌患者接受双重CTLA-4和PD-L1或PD-1阻断治疗及生物标志物基础亚组分析的长期总生存:一项系统评价和重建个体患者数据荟萃分析
err2025-09-29
err0
PREAI
errAlessandro Di Federico; Sara Stumpo; Francesco Mantuano; Andrea De Giglio; Francesca Lo Bianco; Federica Pecci; Joao V Alessi; Xinan Wang; Francesca Sperandi; Barbara Melotti; Francesco Gelsomino; Ferdinandos Skoulidis; Marina C Garassino; Solange Peters; Mark M Awad; Andrea Ardizzoni; Biagio Ricciuti
err分享
err收藏
First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study一线免疫治疗联合或不联合化疗与BRAF联合MEK抑制剂在BRAFV600E突变型转移性非小细胞肺癌中的比较(FRONT-BRAF):一项多中心、回顾性队列研究
err2025-09-29
err0
PREAI
errAlessandro Di Federico; Kaiwen Wang; Monica F Chen; Adam A Barsouk; Arianna Pagliaro; Lanyi N Chen; Francesca R Ogliari; Paul Stockhammer; Rajat Thawani; Shahm Raslan; Eleonora Gariazzo; Francesca Fusco; Grace M Hambelton; Fabrizio Citarella; David Meyer; Mihaela Aldea; Andrea De Giglio; Joao V Alessi; Federica Pecci; Francesco Gelsomino; Marcelo Corassa; Natalie I Vokes; Xinan Wang; Dario de Biase; Fawzi Abu Rous; Phurin Areesawangkit; Omar Elghawy; Alessio Cortellini; Giulio Metro; Roberto Ferrara; Mark M Awad; Aliyah Pabani; Joseph C Murray; Federico Cappuzzo; Marina C Garassino; Ibiayi Dagogo-Jack; Gregory Riely; Michael Grant; Benjamin O Herzberg; Andrea Ardizzoni; David Planchard; Bruce E Johnson; Corey J Langer; Michael Offin; Marcelo V Negrao; Biagio Ricciuti
err分享
err收藏
Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors黏液性组织学特征的肺腺癌:临床、基因组学和免疫微环境特征及对基于免疫疗法治疗和KRASG12C抑制剂的疗效
err2025-03-01
err4
PREAI
errDi Federico, A.; Hong, L.; Elkrief, A.; Thummalapalli, R.; Cooper, A. J.; Ricciuti, B.; Digumarthy, S.; Alessi, J. V.; Gogia, P.; Pecci, F.; Makarem, M.; Gandhi, M. M.; Garbo, E.; Saini, A.; De Giglio, A.; Favorito, V.; Scalera, S.; Cipriani, L.; Marinelli, D.; Haradon, D.; Nguyen, T.; Haradon, J.; Voligny, E.; Vaz, V.; Gelsomino, F.; Sperandi, F.; Melotti, B.; Ladanyi, M.; Zhang, J.; Gibbons, D. L.; Heymach, J. V.; Nishino, M.; Lindsay, J.; Rodig, S. J.; Pfaff, K.; Sholl, L. M.; Wang, X.; Johnson, B. E.; Janne, P. A.; Rekhtman, N.; Maugeri-Sacca, M.; Heist, R. S.; Ardizzoni, A.; Awad, M. M.; Arbour, K. C.; Schoenfeld, A. J.; Vokes, N. I.; Luo, J.
err分享
err收藏
First-line immunotherapy versus BRAF and MEK inhibitors for patients with BRAF V600E mutant metastatic non-small cell lung cancer一线免疫治疗与BRAF和MEK抑制剂在BRAF V600E突变型转移性非小细胞肺癌患者中的应用比较
err2024-09-01
err0
PREAI
errDi Federico, A.; Chen, M. F.; Pagliaro, A.; Ogliari, F. R.; Stockhammer, P.; Aldea, M.; Grant, M.; De Giglio, A.; Alessi, J. V.; Pecci, F.; Gelsomino, F.; Negrao, M. V.; Ferrara, R.; Awad, M.; Riely, G. J.; Ardizzoni, A.; Planchard, D.; Offin, M. D.; Johnson, B. E.; Ricciuti, B.
err分享
err收藏
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed
err2024-05-01
err3
PREAI
errLeonetti, Alessandro; Perrone, Fabiana; Puntoni, Matteo; Maglietta, Giuseppe; Bordi, Paola; Bria, Emilio; Vita, Emanuele; Gelsomino, Francesco; De Giglio, Andrea; Gelibter, Alain; Siringo, Marco; Mazzoni, Francesca; Caliman, Enrico; Genova, Carlo; Bertolini, Federica; Guaitoli, Giorgia; Passiglia, Francesco; Delcuratolo, Marco Donatello; Montrone, Michele; Cerea, Giulio; Pasello, Giulia; Roca, Elisa; Belluomini, Lorenzo; Cecere, Fabiana Letizia; Guida, Annalisa; Manzo, Anna; Adamo, Vincenzo; Rastelli, Francesca; Bulotta, Alessandra; Citarella, Fabrizio; Toschi, Luca; Zoratto, Federica; Cortinovis, Diego Luigi; Berardi, Rossana; Follador, Alessandro; Carta, Annamaria; Camerini, Andrea; Salerno, Flavio; Silva, Rosa Rita; Baldini, Editta; Cortellini, Alessio; Brighenti, Matteo; Santoni, Matteo; Malorgio, Francesco; Caminiti, Caterina; Tiseo, Marcello
err分享
err收藏
Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non-Small-Cell Lung Cancer
err2024-05-01
err4
PREAI
errRiudavets, Mariona; Auclin, Edouard; Mosteiro, Miguel; Dempsey, Naomi; Majem, Margarita; Prelaj, Arsela; Lopez-Castro, Rafael; Bosch-Barrera, Joaquim; Pilotto, Sara; Escalera, Elena; Tagliamento, Marco; Mosquera, Joaquin; Zalcman, Gerard; Nana, Frank Aboubakar; Ponce, Santiago; Albarran-Artahona, Victor; Dal Maso, Alessandro; Spotti, Martina; Mielgo, Xabier; Mussat, Elodie; Reyes, Roxana; Benitez, Jose -Carlos; Lupinacci, Lorena; Duchemann, Boris; De Giglio, Andrea; Blaquier, Juan Bautista; Audigier-Valette, Clarisse; Scheffler, Matthias; Nadal, Ernest; Lopes, Gilberto; Signorelli, Diego; Garcia-Campelo, Rosario; Menis, Jessica; Bluthgen, Virginia; Campayo, Marc; Recondo, Gonzalo; Besse, Benjamin; Mezquita, Laura; Planchard, David
err分享
err收藏
Navigating challenges in EGFR exon 20 insertions: The PAPILLON trial unravels the promise of amivantamab-chemotherapy
errMED
IF11.8
err2024-01-01
err0
errOAAI
errDe Giglio, Andrea; Di Federico, Alessandro; Gariazzo, Eleonora; Metro, Giulio
err分享
err收藏
From Development to Place in Therapy of Lorlatinib for the Treatment of ALK and ROS1 Rearranged Non-Small Cell Lung Cancer (NSCLC)
err2023-12-25
err4
errOAAI
errFabbri, Laura; Di Federico, Alessandro; Astore, Martina; Marchiori, Virginia; Rejtano, Agnese; Seminerio, Renata; Gelsomino, Francesco; De Giglio, Andrea; Tomkowski, Witold Z.
err分享
err收藏
Adjuvant crizotinib treatment selected by patient-derived organoids in a patient with stage IIIA adenocarcinoma with novel LRRTM4-ALK fusion: a case
err2023-11-01
err1
errOAAI
errLi, Bowen; Jia, Ziqi; Huang, Zhicheng; Xue, Jianchao; Wang, Yadong; Guo, Chao; Si, Xiaoyan; Chen, Zexin; Li, Ji; Chen, Rongrong; Bie, Zhixin; De Giglio, Andrea; Christopoulos, Petros; Liang, Naixin; Li, Shanqing
err分享
err收藏
STK11 mutations predict poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemoimmunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 status
err2023-10-01
err0
PREAI
errDe Giglio, A.; de Biase, D.; Di Federico, A.; Maloberti, T.; Casadio, C.; Gruppioni, E.; Altimari, A.; Melotti, B.; Sperandi, F.; Gelsomino, F.; Ardizzoni, A.
err分享
err收藏
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians
err2023-06-21
err17
errOAAI
errRaschi, Emanuel; Rossi, Simone; De Giglio, Andrea; Fusaroli, Michele; Burgazzi, Flavio; Rinaldi, Rita; Potena, Luciano
err分享
err收藏
Clinical Utility and Application of Liquid Biopsy Genotyping in Lung Cancer: A Comprehensive Review
err2023-02-01
err11
errOAAI
errNigro, Maria Concetta; Marchese, Paola Valeria; Deiana, Chiara; Casadio, Chiara; Galvani, Linda; Di Federico, Alessandro; De Giglio, Andrea
err分享
err收藏
Predictors of survival to immunotherapy and chemoimmunotherapy in non-small cell lung cancer: A meta-analysis
err2022-11-02
err13
errOAAI
errFederico, Alessandro Di; Giglio, Andrea De; Gelsomino, Francesco; Sperandi, Francesca; Melotti, Barbara; Ardizzoni, Andrea
err分享
err收藏